Insider · CIK 0001629303
Thomas F. Lesinski
Files at NCMI (National CineMedia, Inc.). First filing Dec 30, 2024, latest Oct 2, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NCMI: National CineMedia, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | National CineMedia, Inc. | $149k 70,933 shares | -11% | 0% from low-51% from high | |
| 20Weak | NCMIsell National CineMedia, Inc. | $110k 31,106 shares | -6% | +10% from low-43% from high | |
| 36Weak | National CineMedia, Inc. | $147k 37,847 shares | -7% | +0% from low-45% from high | |
| 36Weak | National CineMedia, Inc. | $168k 37,834 shares | -8% | +7% from low-38% from high | |
| 31Weak | National CineMedia, Inc. | $145k 30,971 shares | -7% | +10% from low-36% from high | |
| 30Weak | National CineMedia, Inc. | $187k 40,255 shares | -8% | +3% from low-35% from high | |
| 37Weak | National CineMedia, Inc. | $182k 37,828 shares | -8% | 0% from low-34% from high | |
| 60Notable | National CineMedia, Inc. | $1.1M 167,406 shares | -42% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +103,333 | $0.00 | $0 | 653,994 | 10 d ago |
| Oct 1, 2026 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -70,933 | $2.09 | $149k | 583,061 | 10 d ago |
| Sep 30, 2026 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -103,333 | $0.00 | $0 | 0 | 10 d ago |
| Mar 2, 2026 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +49,706 | $0.00 | $0 | 551,503 | Mar 5, 2026 |
| Mar 3, 2026 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -31,106 | $3.55 | $110k | 520,397 | Mar 5, 2026 |
| Mar 2, 2026 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -49,706 | $0.00 | $0 | 0 | Mar 5, 2026 |
| Feb 27, 2026 | NCMI National CineMedia, Inc. | AGrant or award Restricted Stock Unitsderivative | +140,449 | $0.00 | $0 | 140,449 | Mar 3, 2026 |
| Feb 24, 2026 | NCMI National CineMedia, Inc. | AGrant or award Employee stock options (right to buy)derivative | +1,500,000 | $0.00 | $0 | 1,500,000 | Feb 26, 2026 |
| Dec 26, 2025 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +77,500 | $0.00 | $0 | 539,644 | Dec 30, 2025 |
| Dec 29, 2025 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -37,847 | $3.89 | $147k | 501,797 | Dec 30, 2025 |
| Dec 26, 2025 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -77,500 | $0.00 | $0 | 0 | Dec 30, 2025 |
| Sep 30, 2025 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +77,500 | $0.00 | $0 | 499,978 | Oct 2, 2025 |
| Sep 30, 2025 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -37,834 | $4.44 | $168k | 462,144 | Oct 2, 2025 |
| Sep 30, 2025 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -77,500 | $0.00 | $0 | 0 | Oct 2, 2025 |
| Sep 25, 2025 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock10b5-1 | -30,971 | $4.68 | $145k | 422,478 | Sep 29, 2025 |
| Jul 31, 2025 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +74,560 | $0.00 | $0 | 485,793 | Aug 4, 2025 |
| Jul 31, 2025 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -36,393 | $4.65 | $169k | 449,400 | Aug 4, 2025 |
| Aug 1, 2025 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +7,911 | $0.00 | $0 | 457,311 | Aug 4, 2025 |
| Aug 1, 2025 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -3,862 | $4.67 | $18k | 453,449 | Aug 4, 2025 |
| Jul 31, 2025 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -74,560 | $0.00 | $0 | 0 | Aug 4, 2025 |
| Aug 1, 2025 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,911 | $0.00 | $0 | 0 | Aug 4, 2025 |
| Jun 30, 2025 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +77,500 | $0.00 | $0 | 449,061 | Jul 2, 2025 |
| Jun 30, 2025 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -37,828 | $4.82 | $182k | 411,233 | Jul 2, 2025 |
| Jun 30, 2025 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -77,500 | $0.00 | $0 | 0 | Jul 2, 2025 |
| May 5, 2025 | NCMI National CineMedia, Inc. | AGrant or award Restricted Stock Unitsderivative | +89,127 | $0.00 | $0 | 89,127 | May 6, 2025 |
| May 5, 2025 | NCMI National CineMedia, Inc. | AGrant or award Employee stock options (right to buy)derivative | +250,000 | $0.00 | $0 | 250,000 | May 6, 2025 |
| Mar 31, 2025 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +77,500 | $0.00 | $0 | 407,041 | Apr 1, 2025 |
| Mar 31, 2025 | NCMI National CineMedia, Inc. | FTax withholding Common Stock | -35,480 | $5.84 | $207k | 371,561 | Apr 1, 2025 |
| Mar 31, 2025 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -77,500 | $0.00 | $0 | 0 | Apr 1, 2025 |
| Dec 26, 2024 | NCMI National CineMedia, Inc. | MOption exercise Common Stock | +310,000 | $0.00 | $0 | 396,821 | Dec 30, 2024 |
| Dec 26, 2024 | NCMI National CineMedia, Inc. | SOpen-market sale Common Stock | -167,406 | $6.51 | $1.1M | 229,415 | Dec 30, 2024 |
| Dec 26, 2024 | NCMI National CineMedia, Inc. | MOption exercise Restricted Stock Unitsderivative | -310,000 | $0.00 | $0 | 0 | Dec 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.